Liang Huang

22PUBLICATIONS

57CO-AUTHORS

Tissue engineeringHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (22)

Sort by Publication Date:

|Jun 27, 2026

Bispecific antibody engineered extracellular vesicles redirect T cells to prevent postoperative epidural fibrosis.

|May 29, 2026

Unraveling cellular and molecular mechanisms of relapse in CD19/CD22 dual-targeting chimeric antigen receptor T-cell therapy for B-cell acute lymphoblastic leukemia.

|Feb 07, 2026

Engineered extracellular vesicles displaying bi-specific T-cell engagers for targeted therapy of B-cell malignancies.

Xiuxiu Yang, Qian Xu, Jue Wang

|Nov 30, 2025

CD5 ablation enhances persistence and antitumor potency of engineered T cells by mitigating exhaustion and promoting cytotoxicity.

Jia Wu, Jiali Cheng, Li Zhu

|Sep 18, 2024

Asymptomatic multicentric Castleman disease: a potential early stage of idiopathic MCD.

Lu Zhang, Qin-Hua Liu, Hui Zhou

|May 10, 2024

Single-cell analysis of anti-BCMA CAR T cell therapy in patients with central nervous system autoimmunity.

Chuan Qin, Min Zhang, Da-Peng Mou

Pageof 4

Frequent Collaborators

Chunrui Li

Jianfeng Zhou

Min Xiao

Wen Wang

Peng Li

Dai-Shi Tian

Zheng Zhang

Jia Wei

Ellen Puré

Pieter Van Vlierberghe

Frequent Collaborators

Chunrui Li

Jianfeng Zhou

Min Xiao

Wen Wang